Cargando…
36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348338/ https://www.ncbi.nlm.nih.gov/pubmed/27431083 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.06.019 |
_version_ | 1783556794346373120 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7348338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73483382020-07-16 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2016-06 /pmc/articles/PMC7348338/ /pubmed/27431083 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.06.019 Text en 2016年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 短篇论著 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
title | 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
title_full | 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
title_fullStr | 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
title_full_unstemmed | 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
title_short | 36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
title_sort | 36例t细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析 |
topic | 短篇论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348338/ https://www.ncbi.nlm.nih.gov/pubmed/27431083 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.06.019 |
work_keys_str_mv | AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī AT 36lìtxìbāolínbāliúhuànzhěyīxiànyīngyòngshālìdùànzhìliáodelínchuángfēnxī |